Ovid Therapeutics Inc. (OVID) Balance Sheet
As of 2026-06-30 (10-Q), Ovid Therapeutics Inc. (OVID) reported total assets of $232.0M, total liabilities of $22.1M and shareholders' equity of $209.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $11.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OVIDOvid Therapeutics Inc.Follow OVID — free
—
Price chart with a free account
- Market cap
- 421.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 87.1 | 36.5 | 41.9 | 72.0 | 187.8 | 44.9 | 27.0 | 26.3 | 13.2 | 11.3 | |
| Short-term investments | — | 5.0 | 34.8 | — | 0.0 | 84.1 | 78.8 | 26.8 | 56.5 | 105.9 | |
| Current assets | 88.6 | 44.3 | 79.8 | 74.8 | 190.5 | 131.4 | 109.6 | 55.9 | 74.4 | 123.6 | |
| Total assets | 89.5 | 47.6 | 80.8 | 75.9 | 194.5 | 155.3 | 144.0 | 92.2 | 150.9 | 232.0 | |
| Current liabilities | 6.0 | 8.8 | 10.5 | 22.1 | 14.8 | 7.0 | 11.5 | 10.5 | 8.3 | 10.0 | |
| Total liabilities | — | 8.8 | 10.8 | 32.3 | 14.8 | 23.0 | 56.2 | 23.9 | 20.3 | 22.1 | |
| Shareholders' equity | 83.4 | 38.8 | 70.0 | 43.6 | 179.7 | 132.3 | 87.8 | 68.2 | 130.7 | 209.9 |
USD millions · SEC XBRL
Ovid Therapeutics Inc. — questions
- How much cash does Ovid Therapeutics Inc. have?
- $11.3M in cash and cash equivalents as of 2026-06-30.
- What are Ovid Therapeutics Inc.'s total assets?
- $232.0M as of 2026-06-30.
- What is Ovid Therapeutics Inc.'s shareholders' equity?
- $209.9M as of 2026-06-30.
Every figure on this page comes from Ovid Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.